These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6573535

  • 1. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.
    Pollack A, Block NL, Stover BJ, Irvin GL, Fuentes MP, Claflin AJ, Malinin TI.
    J Natl Cancer Inst; 1983 May; 70(5):907-14. PubMed ID: 6573535
    [Abstract] [Full Text] [Related]

  • 2. Flow cytometric analysis of the response of the R3327-G rat prostatic adenocarcinoma to endocrine manipulation.
    Pollack A, Bagwell CB, Block NL, Irvin GL, Claflin AJ, Stover BJ.
    J Surg Oncol; 1981 May; 18(4):389-98. PubMed ID: 7321568
    [Abstract] [Full Text] [Related]

  • 3. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 4. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
    Russo P, Liguori G, Heston WD, Huryk R, Yang CR, Fair WR, Whitmore WF, Herr HW.
    Cancer Res; 1987 Nov 15; 47(22):5967-70. PubMed ID: 3664500
    [Abstract] [Full Text] [Related]

  • 5. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A, Block NL, Stover BJ, Irvin GL.
    Cancer Res; 1985 Mar 15; 45(3):1052-7. PubMed ID: 3971360
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
    Wakisaka M, Drury RE, Kadohama N.
    Hinyokika Kiyo; 1988 Jan 15; 34(1):107-15. PubMed ID: 3376790
    [Abstract] [Full Text] [Related]

  • 7. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A, Westin P, Bergh A, Cajander S, Damber JE.
    Cancer Res; 1994 Jul 01; 54(13):3594-601. PubMed ID: 8012987
    [Abstract] [Full Text] [Related]

  • 8. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
    Pollack A, Irvin GL, Block NL, Lipton RM, Stover BJ, Claflin AJ.
    Cancer Res; 1982 Jun 01; 42(6):2184-90. PubMed ID: 7074599
    [Abstract] [Full Text] [Related]

  • 9. Quiescence in R3327-G rat prostate tumors after androgen ablation.
    Pollack A, Joon DL, Wu CS, Sikes C, Hasegawa M, Terry NH, White RA, Zagars GK, Meistrich ML.
    Cancer Res; 1997 Jun 15; 57(12):2493-500. PubMed ID: 9192831
    [Abstract] [Full Text] [Related]

  • 10. Subcellular distribution in vivo of testosterone and salt extractability of nuclear androgen complexes in the prostate and prostatic adenocarcinoma: effect of estrogen treatment.
    Batra S, Wännman H, Alenfall J, Forsgren B.
    In Vivo; 1992 Jun 15; 6(6):573-8. PubMed ID: 1296804
    [Abstract] [Full Text] [Related]

  • 11. R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
    Dibner JJ, Nakeff A.
    J Natl Cancer Inst; 1983 Jun 15; 70(6):1057-66. PubMed ID: 6574275
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.
    Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET.
    Cancer Res; 2006 Mar 15; 66(6):3087-95. PubMed ID: 16540658
    [Abstract] [Full Text] [Related]

  • 13. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J.
    Prostate; 1996 Jul 15; 29(1):1-14. PubMed ID: 8685049
    [Abstract] [Full Text] [Related]

  • 14. Production of Nb rat carcinoma of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen.
    Noble RL.
    Cancer Res; 1980 Oct 15; 40(10):3547-50. PubMed ID: 7438041
    [Abstract] [Full Text] [Related]

  • 15. Suppression of androgen action and the induction of gross abnormalities of the reproductive tract in male rats treated neonatally with diethylstilbestrol.
    McKinnell C, Atanassova N, Williams K, Fisher JS, Walker M, Turner KJ, Saunders TK, Sharpe RM.
    J Androl; 2001 Oct 15; 22(2):323-38. PubMed ID: 11229807
    [Abstract] [Full Text] [Related]

  • 16. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM, Milholland RJ, Rosen F.
    Cancer Res; 1980 Jul 15; 40(7):2188-93. PubMed ID: 7388787
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ, Pollack A, Malinin T, Block NL, Irvin GL.
    J Natl Cancer Inst; 1982 Jul 15; 69(1):79-87. PubMed ID: 6954325
    [Abstract] [Full Text] [Related]

  • 18. Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
    Isaacs JT.
    Cancer Res; 1982 Dec 15; 42(12):5010-4. PubMed ID: 6215981
    [Abstract] [Full Text] [Related]

  • 19. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathology.
    Drago JR, Gershwin ME, Maurer RE, Ikeda RM, Eckels DD.
    J Natl Cancer Inst; 1979 Apr 15; 62(4):1057-66. PubMed ID: 285279
    [No Abstract] [Full Text] [Related]

  • 20. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE, Isaacs JT.
    Cancer Res; 1982 Aug 15; 42(8):3148-56. PubMed ID: 7093958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.